The availability of a safe blood supply is critical for bothmedical progress and national security. Safety has been increasedby nucleic acidamplification testing, as documented byStramer et al. in this issue of the Journal.1 As health careproviders, public health officials, and providers and usersof donated blood and tissues we strive to improve the safetyof the blood supply and to consider future threats, includingthreats to the safety of the donated tissue supply.
Twenty years ago with tragic consequences upto 1 in 100 blood units in the United States transmitted thehuman . . . [Full Text of this Article]
Source Information
From the Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Md.
Sandusky, G., Dumaual, C., Cheng, L.
(2009). REVIEW PAPER: Human Tissues for Discovery Biomarker Pharmaceutical Research: The Experience of the Indiana University Simon Cancer Center-Lilly Research Labs Tissue/Fluid BioBank. Vet Pathol
46: 2-9
[Full Text]
Begovac, J., Mihaljevic, I., Perrin, L., Laperche, S., Pillonel, J., Herve, P., Prince, A. M., Kainer, M. A., Jarvis, W. R., Stramer, S. L., Dodd, R. Y., Busch, M. P., Goodman, J. L.
(2004). HIV-1 and HCV Infections among Antibody-Negative Blood Donors. NEJM
351: 2232-2235
[Full Text]
(2004). Banked Blood and Tissue: Safer but Still Not Perfect. Journal Watch Cardiology
2004: 5-5
[Full Text]
(2004). Viral Infections from Blood Transfusions and Tissue Grafts: Reducing the Risk. JWatch Infect. Diseases
2004: 3-3
[Full Text]
(2004). Banked Blood and Tissue: Safer but Still Not Perfect. JWatch General
2004: 4-4
[Full Text]